Back to search

Pheon Therapeutics Ltd

09677410

active
Private Limited Company
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)

Details

INNOVATION HOUSE INNOVATION WAY, SANDWICH, CT13 9FF
Incorporated 08/07/2015

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Shaun Kirkpatrick

director · Since 18/09/2015

VENTURE CAPITAL INVESTOR

AMERICAN · UNITED STATES · Age 57

Also on 1 other board

Mr Jonathan Leslie Tobin

director · Since 14/03/2022

VENTURE CAPITALIST

BRITISH · UNITED KINGDOM · Age 43

Also on 3 other boards

Dr Rogier Wouter Rooswinkel

director · Since 14/03/2022

VENTURE CAPITALIST

DUTCH · NETHERLANDS · Age 42

Also on 1 other board

Mr Michael Gladstone

director · Since 14/03/2022

VENTURE CAPITALIST

AMERICAN · UNITED STATES · Age 39

Mr Jeffery Albers

director · Since 01/01/2023

DIRECTOR

AMERICAN · UNITED STATES · Age 54

Mr Cyrus Mozayeni

director · Since 10/07/2023

CEO

AMERICAN · UNITED STATES · Age 51

Mr Cariad Chester

director · Since 29/04/2024

VENTURE CAPITAL INVESTOR

AMERICAN · UNITED STATES · Age 34

Mr Enoch Kariuki

director · Since 04/09/2024

BIOTECH EXECUTIVE AND ADVISOR

AMERICAN · UNITED STATES · Age 44

Mr Samuel Blackman

director · Since 30/06/2025

INDEPENDENT BOARD MEMBER

AMERICAN · UNITED STATES · Age 57

CompanyRankvs 390+ SIC 72110 peers
85

Financial strength100th percentile among SIC peers · 25/25
Employees92th percentile among SIC peers · 14/15
LiquidityCurrent ratio 7.78× · 20/20
Longevity11 years trading (max 15) · 11/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Labgenius Limited
89
9Nuclera Ltd
88
10Aparito Limited
87
39Pheon Therapeutics Ltd
85
How is this score calculated?
Financial strength25/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity11/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/03/2025

Net Worth

£36.4M

Balance sheet strength

Cash

£37.7M

Cash in the bank

Net Current Assets

£36.3M

Working capital

Current Assets

£41.7M

Current Liabilities

£5.4M

Fixed Assets

£54k

Debtors

£4.0M

11avg. employees+2

Balance Sheet

Assets less current liabilities£36.4M
Prepared with Caseware UK (AP4) 2024.0.164

EstimatesDerived

YearCurrent RatioImplied Profit
20257.78+£18.9M
202411.83+£3.4M
20238.66-£9.3M
202264.20+£25.4M
20202.94-£1.3M
20193.29-£1.5M
20185.62—

Derived from filed accounts. Not audited figures.